Reyno Tapia Jr. on Muck Rack

Reyno Tapia Jr.

As seen in: BioSpace
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Reyno

Contact Reyno, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Opinion: Ruling in REGENXBIO-Sarepta Patent Case Threatens Gene Therapy Market

|
By Richard B. Emmons, Christopher R. Cowles, Nicole Kamish, Reyno Tapia Jr.
| BioSpace
Adeno-associated virus (AAV) gene therapy markets reached a combined value of $1.9 billion in 2023 and are forecasted to top $75.1 billion by 2034, Research and Markets reported in May. But a recent ruling by the Delaware District Court invalidating an AAV gene therapy patent threatens to undermine growth in the AAV gene therapy sector and in biotechnology more broadly.
Open in Who Shared Issue with article?
See all 1 articles

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Get in touch with Reyno

Contact Reyno, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified